Want to see USNA full AI Analyst Report?
USNA Stock Chart & Stats
$13.54
-$0.22(-1.60%)
At close: 4:00 PM EDT
$13.54
-$0.22(-1.60%)
Day’s Range― - ―
52-Week Range$12.57 - $32.29
Previous Close$13.95
Volume291.12K
Average Volume (3M)173.43K
Market Cap
$250.36M
Enterprise Value$273.74
Total Cash (Recent Filing)$168.56M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Oct 27, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.21
Shares Outstanding18,476,534
10 Day Avg. Volume170,208
30 Day Avg. Volume173,431
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.12
Revenue Forecast (FY)$945.10M
Bulls Say, Bears Say
Bulls Say
Debt-Free Balance SheetA debt-free balance sheet and positive free cash flow provide resilience while profitability is pressured. This gives USANA flexibility to fund product development, support venture brands, and absorb operational volatility without relying heavily on external financing.
Product Innovation And Retail ExpansionNew products and broader retail distribution can diversify USANA beyond its traditional distributor model. Increasing physical availability supports consumer acquisition, improves channel reach, and may create more durable growth if launches achieve repeat purchasing.
Core Nutrition And China ResilienceStability in the core nutrition business provides an earnings foundation despite weakness in newer ventures. Improving momentum in Mainland China, supported by product launches and incentives, could strengthen a strategically important market over the medium term.
Bears Say
Severe Profitability ErosionOperating profitability has fallen sharply from historical levels despite a strong gross margin, showing that selling, marketing, and other operating costs are absorbing most product economics. Sustained margin compression reduces earnings quality and limits reinvestment capacity.
Declining Revenue And Customer BaseDeclining sales and customer counts indicate pressure on both USANA's established distributor network and its newer subscription business. A smaller active base can weaken repeat purchasing, reduce operating leverage, and make future growth dependent on costly customer acquisition.
Venture Brand Execution RisksHiya's weaker customer-acquisition economics and Rise's packaging failure expose execution risks in the venture portfolio. These issues have already reduced expected sales and margins, while the Hiya impairment signals that recovering prior growth assumptions may take time.
USANA Health News
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $12.57 and its highest was $32.29 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $250.36M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Oct 27, 2026 which is in 63 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Aug 04, 2026. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of $0.43 by -$0.5.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.11.
How many shares outstanding does USANA Health have?
USANA Health has 18,476,534 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of -$0.07 in its last earnings report, missing expectations of $0.43. Following the earnings report the stock price went down -34.197%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
USNA Sentiment 67%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 92.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $543.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USNA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced clear strategic progress (strong balance sheet, stable core nutrition, successful new product launches, and retail expansion for Hiya and Rise) with meaningful near-term operational and financial headwinds (a $29M goodwill impairment for Hiya, a quarterly pre-tax loss with a $9M tax charge, lowered full-year outlook, Hiya DTC marketing pressures, and a Rise packaging disruption). Management emphasized long-term conviction and the ability to invest, but acknowledged near-term impacts to revenue, margins, and tax rates.View all USNA earnings summariesTechnical Analysis
Ownership Overview
40.75% Insiders
10.57% Mutual Funds
14.57% Other Institutional Investors
21.96% Public Companies and
Individual Investors